{"id":"https://openalex.org/W2969696158","doi":"https://doi.org/10.3389/fphar.2019.00537","title":"The Glp-1 Analog Liraglutide Protects Against Angiotensin II and Pressure Overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling","display_name":"The Glp-1 Analog Liraglutide Protects Against Angiotensin II and Pressure Overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling","alternate_titles":[],"publication_year":2019,"publication_date":"2019-06-05","ids":{"openalex":"https://openalex.org/W2969696158","doi":"https://doi.org/10.3389/fphar.2019.00537","mag":"2969696158","pmid":"https://pubmed.ncbi.nlm.nih.gov/31231210","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6560159"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2019.00537","doi":"https://doi.org/10.3389/fphar.2019.00537","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2019.00537","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.00537/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2969696158"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.00537/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100428096","display_name":"Ran Li","orcid":"https://orcid.org/0000-0003-2877-2582","observed_orcids":["https://orcid.org/0000-0003-2877-2582"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ran Li","raw_affiliation_strings":["Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056099055","display_name":"Yingguang Shan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yingguang Shan","raw_affiliation_strings":["Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100750446","display_name":"Lu Gao","orcid":"https://orcid.org/0000-0001-8611-3097","observed_orcids":["https://orcid.org/0000-0001-8611-3097"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lu Gao","raw_affiliation_strings":["Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100442301","display_name":"Xi Wang","orcid":"https://orcid.org/0009-0002-4464-7183","observed_orcids":["https://orcid.org/0009-0002-4464-7183"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xi Wang","raw_affiliation_strings":["Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065430209","display_name":"Xule Wang","orcid":"https://orcid.org/0000-0002-5785-191X","observed_orcids":["https://orcid.org/0000-0002-5785-191X","https://orcid.org/0000-0003-1670-9578"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xule Wang","raw_affiliation_strings":["Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100321431","display_name":"Fang Wang","orcid":"https://orcid.org/0000-0002-7474-9263","observed_orcids":["https://orcid.org/0000-0002-7474-9263"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Fang Wang","raw_affiliation_strings":["Department of Endocrinology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5100321431"],"corresponding_institution_ids":["https://openalex.org/I4210156804"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":2.8787,"has_fulltext":true,"cited_by_count":52,"citation_normalized_percentile":{"value":0.92261443,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"10","issue":null,"first_page":"537","last_page":"537"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.04859999939799309,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8510000109672546},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.8960000276565552},{"id":"https://openalex.org/keywords/pressure-overload","display_name":"pressure overload","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cardiac-hypertrophy","display_name":"cardiac hypertrophy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cardiac-remodeling","display_name":"cardiac remodeling","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9190000295639038},{"id":"https://openalex.org/keywords/ampkalpha2","display_name":"AMPK\u03b12","score":0.6800000071525574},{"id":"https://openalex.org/keywords/mtor","display_name":"mTOR","score":0.7730000019073486},{"id":"https://openalex.org/keywords/coarctation-of-the-aorta","display_name":"coarctation of the aorta","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cardiomyocyte-hypertrophy","display_name":"cardiomyocyte hypertrophy","score":0.8240000009536743},{"id":"https://openalex.org/keywords/cardiac-function","display_name":"cardiac function","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.6761715412139893},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.6688401103019714},{"id":"https://openalex.org/C2780124434","wikidata":"https://www.wikidata.org/wiki/Q12357464","display_name":"AMPK","level":4,"score":0.6328943967819214},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5920704007148743},{"id":"https://openalex.org/C2778271984","wikidata":"https://www.wikidata.org/wiki/Q17126794","display_name":"Pressure overload","level":4,"score":0.5905610918998718},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5839574933052063},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5289419293403625},{"id":"https://openalex.org/C111566952","wikidata":"https://www.wikidata.org/wiki/Q1303462","display_name":"Cardiac function curve","level":3,"score":0.5170734524726868},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4654892683029175},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4215927720069885},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35349512100219727},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3387031555175781},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.33539634943008423},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.3185423016548157},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.29435861110687256},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.2197265625},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.21469110250473022},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.20343852043151855},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.19793152809143066},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.08284309506416321},{"id":"https://openalex.org/C3018791406","wikidata":"https://www.wikidata.org/wiki/Q945225","display_name":"Cardiac hypertrophy","level":3,"score":0.07948446273803711},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2019.00537","doi":"https://doi.org/10.3389/fphar.2019.00537","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2019.00537","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.00537/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5555181","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6560159","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:31231210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31231210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6560159","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6560159/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:34be6ce636e84c28bac74cd3b7d81943","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/34be6ce636e84c28bac74cd3b7d81943","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 10 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2019.00537","doi":"https://doi.org/10.3389/fphar.2019.00537","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2019.00537","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2019.00537/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2969696158.pdf","grobid_xml":"https://content.openalex.org/works/W2969696158.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1614898505","https://openalex.org/W1979389558","https://openalex.org/W1998550705","https://openalex.org/W2000976083","https://openalex.org/W2024031438","https://openalex.org/W2029762560","https://openalex.org/W2041550708","https://openalex.org/W2060836453","https://openalex.org/W2065623326","https://openalex.org/W2067104263","https://openalex.org/W2074305473","https://openalex.org/W2080811589","https://openalex.org/W2087107619","https://openalex.org/W2104818363","https://openalex.org/W2140439371","https://openalex.org/W2145185779","https://openalex.org/W2150913805","https://openalex.org/W2156859545","https://openalex.org/W2166978593","https://openalex.org/W2167467272","https://openalex.org/W2270759340","https://openalex.org/W2336680030","https://openalex.org/W2397175168","https://openalex.org/W2410531044","https://openalex.org/W2415715899","https://openalex.org/W2560350406","https://openalex.org/W2607719937","https://openalex.org/W2612566047","https://openalex.org/W2748662585","https://openalex.org/W2781793537","https://openalex.org/W2789525405","https://openalex.org/W2793903902","https://openalex.org/W2801370619","https://openalex.org/W2808458280","https://openalex.org/W2887194013","https://openalex.org/W2889018234","https://openalex.org/W2912201158","https://openalex.org/W2966756330"],"related_works":["https://openalex.org/W3188113853","https://openalex.org/W3093433501","https://openalex.org/W2612335573","https://openalex.org/W2965236780","https://openalex.org/W2167467272","https://openalex.org/W4319795041","https://openalex.org/W3080953719","https://openalex.org/W2310859294","https://openalex.org/W3015010098","https://openalex.org/W6888938377"],"abstract_inverted_index":{"Glp-1":[0],"analog,":[1],"liraglutide":[2,94],"(Lir),":[3],"have":[4],"been":[5],"shown":[6],"to":[7,54,74,83,112],"reduce":[8],"infarct":[9],"size":[10],"and":[11,33,42,67,103,120,130,141,155],"improve":[12],"cardiac":[13,37,61,85,128,132],"function":[14,133],"after":[15],"myocardial":[16],"ischaemia":[17],"in":[18,39,118,121,174,178],"rodents":[19],"with":[20,92,110],"or":[21,95],"without":[22],"diabetes.":[23],"But":[24],"the":[25,43,56,137,163,169],"effect":[26,57],"of":[27,50,58,139,151,157,166,172],"Lri":[28,173],"on":[29,60],"angiotensin":[30],"II":[31,76],"(AngII)":[32],"pressure":[34],"overload":[35],"induced":[36,63,113],"remodelling":[38,86,115],"non-diabetic":[40],"mice":[41],"underlying":[44],"mechanism":[45],"is":[46,53],"unclear.":[47],"The":[48],"aim":[49],"this":[51],"study":[52],"investigate":[55],"Lir":[59,125],"remodeling":[62],"by":[64],"AngII":[65,111],"infusion,":[66],"explore":[68],"its":[69],"possible":[70],"mechanism.":[71],"Mice":[72,88],"subjected":[73],"Angiotensin":[75],"as":[77,79],"well":[78],"thoracic":[80],"aorta":[81],"coarctation":[82],"induce":[84],"model.":[87,116],"were":[89,108],"daily":[90],"injected":[91],"either":[93],"saline":[96],"for":[97],"2":[98],"weeks.":[99],"Neonatal":[100],"rat":[101],"cardiomyocytes":[102,114],"human":[104],"AC":[105],"cell":[106],"lines":[107],"stimulated":[109],"Both":[117],"vivo":[119,175],"vitro":[122],"experiments":[123],"indicated":[124],"significantly":[126],"inhibited":[127],"hypertrophy":[129],"improved":[131],"through":[134],"directly":[135],"suppressing":[136],"activation":[138],"PI3K/Akt1":[140],"stimulating":[142],"AMPK\u03b1":[143],"signaling":[144],"pathways.":[145],"Moreover,":[146,168],"mTOR":[147],"activator":[148],"(MHY1485),":[149],"overexpression":[150],"constitutively":[152],"active":[153],"Akt,":[154],"knockdown":[156],"AMPKa2":[158,179],"expression":[159],"all":[160],"can":[161],"abolish":[162],"protective":[164,170],"effects":[165,171],"Lri.":[167],"was":[176],"lost":[177],"knockout":[180],"mice.":[181]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2969696158","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2019-08-29T00:00:00"}
